Kidney adiposity in obesity and chronic kidney disease: mechanisms, measurement, and clinical implications
Author:
Open Access
- 22 October 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1967640
Abstract
Kidney outcomes vary substantially among people with similar body mass index (BMI), and conventional measures of obesity do not specify the adipose compartments that lie closest to the kidney or the biological state of those tissues. Human imaging, physiological studies, and paired-tissue analyses now permit a more anatomically explicit account of kidney adiposity. Perirenal adipose tissue (PRAT), renal sinus adipose tissue (RSAT), and intrarenal lipid are distinct constructs and should not be collapsed into a single ‘fatty kidney’ construct. This critical narrative review examines kidney adiposity at the obesity–CKD interface using a claim-conditioned translational evidence continuum spanning association, partial independence from systemic adiposity, prospective association, human mechanistic support, treatment-associated depot remodeling, depot–renal response linkage, causal mediation, and treatment-effect modification. Selected kidney-associated fat measures are associated with albuminuria, filtration, intrarenal haemodynamics, and CKD status, and some signals persist after adjustment for BMI or visceral adipose tissue. In paired tissue from healthy kidney donors, PRAT and RSAT show distinct metabolic and immune profiles. However, much of the human evidence derives from cohorts enriched for type 2 diabetes, which limits extrapolation to non-diabetic obesity-associated CKD. Acquisition, segmentation, normalisation, external validation, and clinically useful thresholds also remain unsettled. Intervention studies show that selected kidney-associated fat measures can change with lifestyle or sodium-glucose cotransporter-2 inhibition, whereas major kidney-outcome trials often did not measure kidney-adiposity compartments. These parallel observations do not establish that depot remodeling mediates renal protection. Compartment-resolved assessment of kidney adiposity should therefore be regarded as a research strategy rather than a clinical classification. Its future value depends on incremental prognostic or decision information beyond eGFR, albuminuria, and validated CKD risk models, and on direct testing of whether depot modification contributes causally to kidney response.Keywords
This publication has 40 references indexed in Scilit:
- Functional genomics reveals adipose-kidney crosstalk as a contributor to kidney fibrosis via the OSM-OSMR pathwayFunctional & Integrative Genomics, 2025
- Ultrasound measurement of perirenal adipose tissue indicates cardiovascular disease, but standardisation is needed: A systematic reviewAustralasian Journal of Ultrasound in Medicine, 2024
- Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistanceDiabetes & Metabolism, 2024
- The Kidney in Obesity: Current Evidence, Perspectives and ControversiesCurrent Obesity Reports, 2024
- Renal fat deposition measured on dixon-based MRI is significantly associated with early kidney damage in obesityAbdominal Radiology, 2024
- MR Assessed Changes of Renal Sinus Fat in Response to Glucose Regulation in West European and South Asian Patients With Type 2 DiabetesJournal of Magnetic Resonance Imaging, 2023
- Abdominal adipose tissue and type 2 diabetic kidney disease: adipose radiology assessment, impact, and mechanismsAbdominal Radiology, 2023
- Prognostic impact of renal sinus fat accumulation in patients with chronic kidney diseaseClinical and Experimental Nephrology, 2023
- Renal sinus fat and renal hemodynamics: a cross-sectional analysisMagnetic Resonance Materials in Physics, Biology and Medicine, 2019
- Changes of renal sinus fat and renal parenchymal fat during an 18-month randomized weight loss trialClinical Nutrition, 2018